AstraZeneca Expands Cancer Treatments With Fusion Buy
Wall Street Journal
AstraZeneca is buying Fusion Pharmaceuticals for up to $2.4 billion as part of a plan to accelerate the development of next-generation cancer treatments.
https://www.wsj.com/articles/astrazeneca-buys-fusion-for-initial-2-bln-ce391059